BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13005802)

  • 1. [Intravenous iron].
    DUFRESNE RR
    Union Med Can; 1952 Jun; 81(6):697-8. PubMed ID: 13005802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tolerance of intravenous iron application].
    GOLDECK H; REMY D; MEYER F
    Arztl Wochensch; 1952 May; 7(21):489-90. PubMed ID: 14952397
    [No Abstract]   [Full Text] [Related]  

  • 3. [The passage of intravenously injected iron from the blood stream].
    OVERKAMP H
    Z Gesamte Exp Med; 1952; 120(1):86-95. PubMed ID: 13057308
    [No Abstract]   [Full Text] [Related]  

  • 4. [The behavior of intravenously administered iron in the organism].
    LINTZEL W
    Arztl Forsch; 1953 Mar; 7(3):I/134-6. PubMed ID: 13065190
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron in hematology: Danger with IV iron: Real or perceived?
    Auerbach M
    Am J Hematol; 2014 Jun; 89(6):664. PubMed ID: 24639085
    [No Abstract]   [Full Text] [Related]  

  • 6. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Balancing Benefits and Safety with Intravenous Iron Treatment.
    Alan Brookhart M; Li X; Kshirsagar AV
    Semin Dial; 2017 Jan; 30(1):25-27. PubMed ID: 27766683
    [No Abstract]   [Full Text] [Related]  

  • 7. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Benefits of Intravenous Iron.
    Wish JB
    Semin Dial; 2017 Jan; 30(1):20-22. PubMed ID: 27679413
    [No Abstract]   [Full Text] [Related]  

  • 8. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Emerging Evidence on the Safety of Intravenous Iron in Chronic Kidney Disease.
    Agarwal R
    Semin Dial; 2017 Jan; 30(1):22-25. PubMed ID: 27678472
    [No Abstract]   [Full Text] [Related]  

  • 9. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Role for Newly Approved Iron Treatments.
    Fishbane S
    Semin Dial; 2017 Jan; 30(1):27-29. PubMed ID: 27687015
    [No Abstract]   [Full Text] [Related]  

  • 10. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: How Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors May Change Iron Management in End-Stage Renal Disease.
    Besarab A; Szczech L
    Semin Dial; 2017 Jan; 30(1):29-31. PubMed ID: 27699882
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous iron therapy].
    Med Contemp; 1952 May; 70(5):299-301. PubMed ID: 14956388
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous iron therapy.
    VARIAVA NS
    Antiseptic; 1952 Mar; 49(3):210-7. PubMed ID: 14934073
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with intravenous iron therapy].
    SELIGER H
    Ther Ggw; 1952 Feb; 91(2):55-7. PubMed ID: 14922346
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review.
    Daniilidis A; Panteleris N; Vlachaki E; Breymann C; Assimakopoulos E
    J Obstet Gynaecol; 2018 May; 38(4):443-447. PubMed ID: 29057687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous iron therapy with ferrum injectabile Vitis].
    PRIBILLA W
    Medizinische; 1952 Jun; 2():53-6. PubMed ID: 14940483
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous iron therapy in pediatrics.
    HAGBERG B
    Acta Paediatr (Stockh); 1951 Nov; 40(6):519-40. PubMed ID: 14933007
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron Treatment Strategies in Nondialysis CKD.
    Macdougall IC
    Semin Nephrol; 2016 Mar; 36(2):99-104. PubMed ID: 27236130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma iron levels after the intravenous administration of different iron preparations.
    NISSIM JA
    J Physiol; 1952 Dec; 118(4):63P-64P. PubMed ID: 13023666
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous administration of iron gluconate during haemodialysis.
    Calvar C; Mata D; Alonso C; Ramos B; Lopez de Novales E
    Nephrol Dial Transplant; 1997 Mar; 12(3):574-5. PubMed ID: 9075144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Irritative effects of intravenous administration of iron-glucose solutions].
    WIESENER H
    Dtsch Med J; 1952 Jun; 3(11-12):253-4. PubMed ID: 12979956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.